https://www.kletthamerinsights.com/novo-nordisk-will-the-shopping-list-of-the-insulin-maker-deliver/2026-07-16T16:36:39.582Zhttps://storage.ghost.io/c/40/b0/40b05486-e5cc-4f80-89a2-d845de0ff6a1/content/images/2026/06/novo_nordisk_insulin-1-1.jpegnovo_nordisk_insulin-1-1.jpeghttps://www.kletthamerinsights.com/pfizer-spent-43-bn-to-become-a-anti-cancer-company-and-spent-another-10-bn-to-become-a-anti-obesity-company-what-is-pfizer-actually-building/2026-07-15T14:24:10.000Zhttps://storage.ghost.io/c/40/b0/40b05486-e5cc-4f80-89a2-d845de0ff6a1/content/images/2026/07/Pfizer_visualization_Gemini.pngPfizer_visualization_Gemini.pnghttps://www.kletthamerinsights.com/mercks-cos-external-capital-allocation-sprint-against-the-keytruda-patent-cliff/2026-07-15T07:43:43.000Zhttps://storage.ghost.io/c/40/b0/40b05486-e5cc-4f80-89a2-d845de0ff6a1/content/images/2026/07/Merck---Co_patent-cliff-visualisation.pngMerck---Co_patent-cliff-visualisation.pnghttps://www.kletthamerinsights.com/eli-lilly-will-this-trillion-dollar-juggernaut-continue-to-roll/2026-07-13T15:53:47.000Zhttps://storage.ghost.io/c/40/b0/40b05486-e5cc-4f80-89a2-d845de0ff6a1/content/images/2026/07/Lilly-juggernaut-visualisation_Gemini.pngLilly-juggernaut-visualisation_Gemini.pnghttps://www.kletthamerinsights.com/building-through-buying-will-astrazenecas-open-innovation-engine-turn-it-into-the-next-most-valuable-pharma-company/2026-07-13T13:25:31.000Zhttps://storage.ghost.io/c/40/b0/40b05486-e5cc-4f80-89a2-d845de0ff6a1/content/images/2026/06/AZ-campus_Gemini_Generated.pngAZ-campus_Gemini_Generated.pnghttps://www.kletthamerinsights.com/the-85-billion-shopping-spree-how-abbvie-bought-borrowed-and-built-its-way-out-of-a-humira-cliff/2026-07-13T10:16:53.000Zhttps://storage.ghost.io/c/40/b0/40b05486-e5cc-4f80-89a2-d845de0ff6a1/content/images/2026/07/AbbVie_Gemini_Image_Kletthamer.pngAbbVie_Gemini_Image_Kletthamer.png